latest company annoucement validates long term
potential growth,the asthma and insulin world market is huge.
Map pharma products are far superior to conventional
products .
once the human trials are finished and the technology
does work 30cents plus.
EIF
eiffel technologies limited
great buying opportunity
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)